Clinical utility of lanreotide Autogel(®) in gastroenteropancreatic neuroendocrine tumors

Somatostatin analogs (SSAs), which were initially used to control hormonal syndromes associated with neuroendocrine neoplasms (NENs), have been successfully proposed as antiproliferative agents, able to control tumor growth in patients affected by gastroenteropancreatic (GEP)-NENs. The development o...

Descripción completa

Detalles Bibliográficos
Autores principales: Paragliola, Rosa Maria, Prete, Alessandro, Papi, Giampaolo, Torino, Francesco, Corsello, Andrea, Pontecorvi, Alfredo, Corsello, Salvatore Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087808/
https://www.ncbi.nlm.nih.gov/pubmed/27822010
http://dx.doi.org/10.2147/DDDT.S76732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087808/
https://www.ncbi.nlm.nih.gov/pubmed/27822010
http://dx.doi.org/10.2147/DDDT.S76732

Ejemplares similares